Related Experiment Video

Updated: Jun 3, 2026

Analysis of Translation Initiation During Stress Conditions by Polysome Profiling
10:59

Analysis of Translation Initiation During Stress Conditions by Polysome Profiling

Published on: May 19, 2014

A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation

Sabine Lecosnier1, Céline Cordier, Philippe Simon

  • 1Centre National de la Recherche Scientifique, Muséum National d'Histoire Naturelle, Unité Mixte de Recherche 7196, Paris, France.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|March 16, 2011
PubMed

Insights

Polypyrimidic peptide nucleic acids (PNAs) effectively target the insulin-like growth factor 1 receptor (IGF-1R) mRNA. This novel approach inhibits cancer cell growth by down-regulating IGF-1R expression at the translational level.

Area of Science:

  • Molecular Biology
  • Cancer Therapeutics
  • Oligonucleotide Therapeutics

Background:

  • Insulin-like growth factor 1 receptor (IGF-1R) is crucial for cell growth and survival.
  • IGF-1R is frequently overexpressed in various cancers, making it a significant therapeutic target.
  • Polypyrimidic peptide nucleic acids (PNAs) are known to form triplex structures with mRNA and inhibit translation.

Purpose of the Study:

  • To investigate the efficacy of a specific PNA in down-regulating IGF-1R expression in prostate cancer cells.
  • To determine the mechanism of PNA-mediated inhibition, specifically at the translational level.
  • To assess the impact of IGF-1R knockdown on downstream signaling pathways and cell transformation.

Main Methods:

  • A 17-mer PNA designed to bind the IGF-1R mRNA was synthesized and tested in vitro and in prostate cancer cells.
  • Quantitative RT-PCR was used to measure IGF-1R mRNA levels.
  • Western blotting was employed to analyze the phosphorylation status of PI3K/AKT and MAPK signaling pathways.
  • Cell transformation assays were conducted to evaluate the functional impact of PNA treatment.

Main Results:

  • The PNA significantly down-regulated IGF-1R expression by 70-80% in prostate cancer cells without affecting insulin receptor expression.
  • IGF-1R mRNA levels remained unchanged, confirming inhibition at the translational level.
  • PNA treatment led to reduced phosphorylation of PI3K/AKT and MAPK pathways and decreased cell transformation.
  • PNA demonstrated a unique ability to form triplex structures with mRNA and arrest translation elongation compared to other steric blockers.

Conclusions:

  • PNAs represent a promising therapeutic strategy for targeting IGF-1R in cancer.
  • PNA-mediated translational inhibition offers a specific and effective approach to down-regulate oncogenic receptor expression.
  • This study highlights the potential of PNA technology in developing novel anticancer therapies by modulating key signaling pathways.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...